Defective trophoblast function in mice with a targeted mutation of Ets2

Genes and Development

Volumn 12, Issue 9, 1998, Pages 1315-1326

  Yamamoto, Hideyuki ^a   Flannery, Margaret L ^b   Kupriyanov, Sergey ^a   Pearce, Jonathan ^c   McKercher, Scott R ^a   Henkel, Gregory W ^a   Maki, Richard A ^a   Werb, Zena ^b   Oshima, Robert G ^a  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Ets2; FGF; Proteinase; TGF ; Transcription; Trophoblast

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GELATINASE B; MATRIX METALLOPROTEINASE; STROMELYSIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 2; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL TYPE; CONTROLLED STUDY; EMBRYO; EMBRYO DEATH; EXTRACELLULAR MATRIX; FIBROBLAST; GENE DELETION; GENE TARGETING; GROWTH REGULATION; HAIR GROWTH; LETHALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA FUNCTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; TROPHOBLAST;

ANIMALIA; MAMMALIA; RODENTIA;

EID: 0032079317     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.9.1315     Document Type: Article

References (65)

1. Alexander, C.M., E.J. Hansell, O. Behrendtsen, M.L. Flannery, N.S. Kishnani, S.P. Hawkes, and Z. Werb. 1996. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 122: 1723-1736.
2. Behrendtsen, O. and Z. Werb. 1997. Metaloproteinases regulate differentiation and migration of parietal endoderm in mouse embryos. Dev. Dyn. 208: 255-265.
3. Behrendtsen, O., C.M. Alexander, and Z. Werb. 1992. Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. Development 114: 447-456.
4. Beitel, G.J., S. Tuck, I. Greenwald, and H.R. Horvitz. 1995. The Caenorhabditis elegans gene lin-1 enclodes an ETS-domain protein and defines a branch of the vulval induction pathway. Genes &. Dev. 9: 3149-3162.
5. Berkowitz, E.A., K.B. Seroogy, J.A. Schroder, W.E. Russell, E.P. Evans, R.F. Riedel, H.K. Phillips, C.A. Harrison, D.C. Lee, and N.C. Luetteke. 1996. Characterization of the mouse tranforming growth factor a gene: Its expression during eye-lid development and in Waved 1 tissues. Cell Growth Differ. 7: 1271-1282.
6. Bortner, D.M., S.J. Langer, and M.C. Ostrowski. 1993. Non-nuclear oncogenes and the regulation of gene expression in transformed cells. Crit. Rev. Oncol. 4: 137-160.
7. Boulukos, K.E., P. Pognonec, B. Rabault, A. Begue, and J. Ghysdael. 1989. Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro. Mol. Cell. Biol. 9: 5718-5721.
8. Boulukos, K.E., P. Pognonec, E. Sariban, M. Bailly, C. Lagrou, and J. Ghysdael. 1990. Rapid and transient expression of Ets2 in mature macrophages following stimulation with CMGF, LPS, and PKC activators. Genes & Dev. 4: 401-409.
9. Brunner, D., K. Dücker, N. Oellers, E. Hafen, H. Scholz, and C. Klämbt. 1994. The ETS domain protein Pointed-P2 is a target of MAP kinase in the Sevenless signal transduction pathway. Nature 370: 386-389.
10. Chen, W.S., K. Manova, D.C. Weinstein, S.A. Duncan, A.S. Plump, V.R. Prezioso, R.F. Bachvarova, and J.E. Darnell Jr. 1994. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and imparied gastrulation of mouse embryos. Genes & Dev. 8: 2466-2477.
11. Chomcznski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
12. Copp, A.J. 1995. Death before birth: Clues from gene knockouts and mutations. Trends Genet. 11: 87-93.
13. Donaldson, L.W., J.M. Petersen, B.J. Graves, and L.P. McIntosh. 1994. Secondary structure of the ETS domain places murine Ets-1 in the superfamily of winged helix-turn-helix DNA-binding proteins. Biochemistry 33: 13,509-13,516.
14. Duncan, S.A., A. Nagy, and W. Chan. 1997. Murine gastrulation requires HNF-4 regulated gene expression in the visceral endoderm: tetraploid rescue of Hnf-4-/-embryos. Development 124: 279-287.
15. Fujiwara, S., R.J. Fisher, N.K. Bhat, S. Espina, M. Diazdela, and T.S. Papas. 1988. A short-lived nuclear phosphoprotein encoded by the human ets-2 proto-oncogene is stabilized by activation of protein kinase C. Mol. Cell. Biol. 8: 4700-4706.
16. Gack, S., R. Vallon, J. Schaper, U. Ruther, and P. Angel. 1994. Phenotypic alterations in Fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. J. Biol. Chem. 269: 10363-10369.
17. Galang, C.K., C.J. Der, and C.A. Hauser. 1994. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. Oncogene 9: 2913-2921.
18. Galang, C.K., J.J. Garcia-Ramirez, P.A. Solski, C.J. Der, N.N. Neznanov, R.G. Oshima, and C.A. Hauser. 1996. Oncogenic neu/ErbB-2 increases Ets, AP-1, and NF-kB-dependent gene expression, and inhibiting Ets activation blocks Neu-mediated cellular transformation. J. Biol. Chem. 271: 7992-7998.
19. Ghysdael, J. and A. Boureux. 1997. The ETS family of transcriptional regulators. In Oncogenes as Transcriptional Regulators (ed. B. Yaniv and J. Ghysdael), pp. 29-89. Birkhauser Verlag, Basel, Switzerland.
20. Guillemot, F., A. Nagy, A. Auerbach, J. Rossant, and A.L. Joyner. 1994. Essential role of mash-2 in extraembryonic development. Nature 371: 333-336.
21. Gum, R., E. Lengyel, J. Juarez, J.H. Chen, H. Sato, M. Seiki, and D. Boyd. 1996. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem. 271: 10672-10680.
22. Gutman, A. and B. Wasylyk. 1990. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J. 9: 2241-2246.
23. Hardy, M.H. 1992. The secret life of the hair follicle. Trends Genet. 8: 55-61.
24. Hebert, J.M., T. Rosenquist, J. Gotz, and G.R. Martin. 1994. FGF5 as a regulator of the hair growth cycle: Evidence from targeted and spontaneous mutations. Cell 78: 1017-1025.
25. Henkel, G.W., S.R. McKercher, H. Yamamoto, K.L. Anderson, R.G. Oshima, and R.A. Maki. 1996. PU.1 but not Ets-2 is essential for macrophage development from ES cells. Blood 88: 2917-2926.
26. Henrique, D., J. Adam, A. Myat, A. Chitnis, J. Lewis, and D. Ish-Horowicz. 1995. Expression of a Delta homologue in prospective neurons in the chick. Nature 375: 787-790.
27. Wis mutant embryos. Development 113: 913-917.
28. Hogan, B., F. Costantini, and E. Lacy. 1986. Manipulating the mouse embryo: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
29. Karim, F.D., L.D. Urness, C.S. Thummel, M.J. Klemsz, S.R. McKercher, A. Celada, C. VanBeveren, and R.A. Maki. 1990. The ETS domain: A new DNA binding motif that recognizes a purine-rich core DNA sequence. Genes &. Dev. 4: 1451-1453.
30. Kodandapani, R., F. Pio, C.-Z. Ni, G. Piccialli, M. Klemsz, S. McKercher, R.A. Maki, and K.R. Ely. 1996. A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA complex. Nature 380: 456-460.
31. Liang, H., E.T. Olejniczak, X. Mao, D.G. Nettesheim, L. Yu, C.B. Thompson, and S.W. Fesik. 1994. The secondary structure of the ets domain of human Fli-1 resembles that of the helix-turn-helix DNA-binding motif of the Escherichia coli catabolite gene activator protein. Proc. Natl. Acad. Sci. 91: 11655-11659.
32. Logan, S.K., M.J. Garabedian, C.E. Campbell, and Z. Werb. 1996. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J. Biol. Chem. 271: 774-782.
33. Luetteke, N.C., T.H. Qiu, R.L. Peiffer, P. Oliver, O. Smithies, and D.C. Lee. 1993. TGFa deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73: 263-278.
34. Luetteke, N.C., H.K. Phillips, T.H. Qiu, N.G. Copeland, H.S. Earp, N.A. Jenkins, and D.C. Lee. 1994. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes &. Dev. 8: 399-413.
35. Luo, J., R. Sladek, J.-A. Bader, A. Matthyssen, J. Rossant, and V. Giguere. 1997. Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-β. Nature 388: 778-782.
36. Mann, G.B., K.J. Fowler, A. Gabriel, E.C. Nice, R.L. Williams, and A.R. Dunn. 1993. Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73: 249-261.
37. Maroulakou, I.G., T.S. Papas, and J.E. Green. 1994. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene 9: 1551-1565.
38. McCarthy, S.A., D. Chen, B.-S. Yang, J.J. Garcia Ramirez, H. Cherwinski, X.-R. Chen, M. Klagsbrun, C.A. Hauser, M.C. Ostrowski, and M. McMachon. 1997. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 17: 2401-2412.
39. McDonnell, S. and L.M. Matrisian. 1990. Stromelysin in tumor progression and metastasis. Cancer Metastasis Rev. 9: 305-319.
40. McKercher, S.R., B.E. Torbett, K.L. Anderson, G.W. Henkel, D.J. Vestal, H. Baribault, M. Klemsz, A.J. Feeney, G.E. Wu, C.J. Paige, and R.A. Maki. 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15: 5647-5658.
41. Miettinen, P.J., J.E. Berger, J. Meneses, Y. Phung, R.A. Pedersen, Z. Werb, and R. Derynck. 1995. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376: 337-341.
42. Mohammad, M., I. Dikic, A. Sorokin, W.H. Burgess, M. Jaye, and J. Schlessinger. 1996. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16:977-989.
43. Muthusamy, N., K. Barton, and J.M. Leiden. 1995. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 377: 639-642.
44. Nagy, A., E. Gocza, E. Merentes-Diaz, V.R. Prideaux, E. Ivanyi, M. Markkula, and J. Rossant. 1990. Embryonic stem cells alone are able to support fetal development in the mouse. Development 110: 815-821.
45. Neznanov, N.S. and R.G. Oshima. 1993. Cis regulation of the keratin 18 gene in transgenic mice. Mol. Cell. Biol. 13: 1815-1823.
46. O'Neill, E.M., I. Rebay, R. Tijan, and G.M. Rubin. 1994. The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/ MAPK pathway. Cell 78: 137-147.
47. Oshima, R.G. 1981. Identification and immunoprecipitation of cytoskeletal proteins from murine extra-embryonic endodermal cells. J. Biol. Chem. 256: 8124-8133.
48. Oshima, R.G., J. McKerrow, and D. Cox. 1981. Murine embryonal carcinoma hybrids: Decreased abiltiy to spontaneoulsy differentiate as a dominat trait. J. Cell Physiol. 109: 195-204.
49. Rabault, B., M.F. Roussel, C.T. Quang, and J. Ghysdael. 1996. Phosphorylation of Ets1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis. Oncogene 13: 877-881.
50. Rees, S., J. Coote, J. Stables, S. Goodson, S. Harris, and M.G. Lee. 1996. Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. BioTechniques 20: 102-110.
51. Reponen, P., C. Sahlberg, C. Munaut, I. Thesleff, and K. Tryggvason. 1994. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J. Cell Biol. 124: 1091-1102.
52. Rippe, R.A., S. Lorenzen, D.A. Brenner, and M. Breindl. 1989. Regulatory elements in the 5′-flanking region and the first intron contribute to the transcriptional control of the mouse alpha 1 type I collagen gene. Mol. Cell. Biol. 9: 2224-2227.
53. Scott, E.W., M.C. Simon, J. Anastasi, and H. Singh. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265: 1573-1577.
54. Sibilia, M. and E.F. Wagner. 1995. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269: 234-238.
55. Stewart, T.A. and B. Mintz. 1981. Successive generations of mice produced from an established culture line of euploid teratocarcinoma cells. Proc. Natl. Acad. Sci. 78: 6314-6318.
56. Sympson, C.J., R.S. Talhouk, C.M. Alexander, J.R. Chin, S.M. Clift, M.J. Bissell, and Z. Werb. 1994. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125: 681-693.
57. Sympson, C.J., R.S. Talhouk, M.J. Bissell, and Z. Werb. 1995. The role of metalloproteinases and their inhibitors in regulating mammary epithelial morphology and function in vivo. Perspectives Drug Discovery Design 2: 401-411.
58. Threadgill, D.W., A.A. Dlugosz, L.A. Hansen, T. Tennenbaum, U. Lichti, D. Yee, C. LaMantia, T. Mourton, K. Herrup, R.C. Harris, J.A. Barnard, S.H. Yuspa, R.J. Coffey, and T. Magnuson. 1995. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230-234.
59. Vecchi, A., C. Garlanda, M.G. Lampugnani, M. Resnati, C. Matteucci, A. Stopparcciaro, H. Schnurch, W. Risau, L. Ruco, A. Mantovani, and E. Dejana. 1994. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application to the identification of adult and embryonic endothelium. Eur. J. Cell Biol. 63: 247-254.
60. Wasylyk, C., A. Gutman, R. Nicholson, and B. Wasylyk. 1991. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J. 10: 1127-1134.
61. Wasylyk, B., S.L. Hahn, and A. Giovane. 1993. The Ets family of transcription factors. Eur. J. Biochem. 211: 7-18.
62. Watson, D.K., G.J. Mavrothalassitis, C.L. Jorcyk, F.E. Smyth, and T.S. Papas. 1990. Molecular organization and differential polyadenylation sites of the human ETS2 gene. Oncogene 5: 1521-1527.
63. Yamaguchi, T.P. and J. Rossant. 1995. Fibroblast growth factors in mammalian development. Cun. Opin. Genet. Dev. 5: 485-491.
64. Yang, B.-S., C.A. Hauser, G. Henkel, M.S. Colman, C. Van Beveren, K.J. Stacey, D.A. Hume, R.A. Maki, and M.C. Ostrowski. 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activity of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16: 538-547.
65. Zeitlin, S., J.-P. Liu, D.L. Chapman, V.E. Papaioannou, and A. Efstratiadis. 1995. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet. 11: 155-163.